Diclofenac Impurity 31 | CAS 575-90-6 - Request Quote
Diclofenac Impurity 31
| SZ CAT No: | SZ-D028054 |
| CAS No | 575-90-6 |
| Mol.F. | C8H6Cl2O3 |
| Mol.Wt. | 221.0 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 2133820-16-1 (sodium salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Diclofenac Impurity 31 is chemically 2-(2,6-Dichlorophenoxy)acetic acid. Diclofenac Impurity 31 is supplied with detailed characterization data compliant with regulatory guideline. Diclofenac Impurity 31 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Diclofenac.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 575-90-6
Purchase 575-90-6
Order 575-90-6
Enquire 575-90-6
price of 575-90-6
575-90-6 Supplier
575-90-6 Manufacturer
575-90-6 Exporter
buy high quality Diclofenac Impurity 31
Purchase Diclofenac Impurity 31
Diclofenac Impurity 31 suppliers
Diclofenac Impurity 31 manufacturers
Diclofenac Impurity 31 price
Order Diclofenac Impurity 31
Enquire Diclofenac Impurity 31
Diclofenac Impurity 31 cost
Diclofenac Impurity 31 Supplier
Diclofenac Impurity 31 Distributor
Diclofenac Impurity 31 for Method Validation
Diclofenac Reference Standard
Diclofenac Impurity 31 for ANDA Filing
Diclofenac Impurity 31 for Forced Degradation Studies
Diclofenac Impurity 31 Identification Standards
Diclofenac Impurity 31 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.